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Abstract
Objective
The glutathione system plays an essential role in antioxidant defense after surgery. We
assessed the effects of intensive insulin treatment (IIT) on glutathione synthesis rate and
redox balance in cancer patients, who had developed stress hyperglycemia after major
surgery.
Methods
We evaluated 10 non-diabetic cancer patients the day after radical abdominal surgery com-
bined with intra-operative radiation therapy. In each patient, a 24-hr period of IIT, aimed at
tight euglycemic control, was preceded, or followed, by a 24-hr period of conventional insulin
treatment (CIT) (control regimen). Insulin was administered for 24 hours, during total paren-
teral nutrition, at a dosage to maintain a moderate hyperglycemia in CIT, and normoglyce-
mic blood glucose levels in IIT (9.3±0.5 vs 6.5±0.3 mmol/L respectively, P<0.001; coefficient
of variation, 9.7±1.4 and 10.5±1.1%, P = 0.43). No hypoglycemia (i.e., blood glucose < 3.9
mmol/L) was observed in any of the patients. Insulin treatments were performed on the first
and second day after surgery, in randomized order, according to a crossover experimental
design. Plasma concentrations of thiobarbituric acid reactive substances (TBARS) and
erythrocyte glutathione synthesis rates (EGSR), measured by primed-constant infusion of
L-[2H2]cysteine, were assessed at the end of each 24-hr period of either IIT or CIT.
Results
Compared to CIT, IIT was associated with higher EGSR (2.70±0.51 versus 1.18±0.29
mmol/L/day, p = 0.01) and lower (p = 0.04) plasma TBARS concentrations (2.2±0.2 versus
2.9±0.4 nmol/L).
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Conclusions
In patients developing stress hyperglycemia after major surgery, IIT, in absence of hypogly-
cemia, stimulates erythrocyte glutathione synthesis, while decreasing oxidative stress.
Introduction
Stress hyperglycemia, associated with insulin resistance, is a common consequence of major
surgery, both in patients with, or without, diabetes mellitus [1]. Van der Berghe et al. showed
that an intensive insulin treatment (IIT), targeted at blood glucose level of 4.4–6.1 mmol/L, in
intensive care unit (ICU) post-surgical patients, can improve their outcome [2]. Subsequent
trials [3–7], however, showed no benefits, or even increased mortality, from such tight glucose
control. [3–8]. Current guidelines recommend to apply, in both critically and non-critically ill
ICU patients, with blood glucose levels >180 mg/dL (10.0 mmol/L), a conventional insulin
treatment (CIT), aimed at a target glycaemia between 140–180 mg/dL (7.8–10.0 mmol/L) [9–
11].
Other authors however, suggest that IIT efficacy, in improving outcomes, depends mostly
on the patient’s clinical conditions, being more beneficial in surgical vs non-surgical ICU
patients and in non-diabetic and non-critically ill hospitalized cases [1,12–15]. Improved out-
come associated with IIT in surgical patients appears to be mainly the result of a reduced risk
of hospital-acquired infections [1,12–16]. Continuous blood glucose–monitoring devices and
computer-assisted closed loop systems for insulin delivery can prevent hypoglycemia and limit
glucose level variability [17]. These methods have been recently applied to test the effects of a
tight glucose control after hepatobiliary-pancreatic surgery [18]. Compared to CIT, IIT was
associated with a 58% and 54% reduction respectively in surgical site infections and pancreatic
fistula [18].
Oxidative stress can impair immunity and increase complications induced by glycemic var-
iability, such as infections and organ dysfunction [19]. Insulin deficiency and hyperglycemia
can directly increase free radical production and impair antioxidant defenses [20]. The tripep-
tide glutathione is the most important endogenous antioxidant in humans [20]; its synthesis
starts with the formation of the dipeptide gamma-glutamyl-cysteine, regulated by the gluta-
myl-cysteinil ligase, followed by the addition of glycine, catalyzed by glutathione synthetase,
[20]. The glutathione availability depends on glutathione peroxidase, which catalyzes the for-
mation of glutathione disulfide (dimeric form), from monomeric glutathione, during hydro-
peroxide reduction, and glutathione reductase, that regenerates the monomeric active form.
Stress hormones and cytokines can down-regulate glutathione synthesis, while insulin up-reg-
ulates gamma-glutamyl-cysteinil ligase [20–24]. In addition, cysteine, the key precursor amino
acid, is the rate-limiting metabolite [20]. Glutathione availability has been shown to be
decreased in surgical trauma and other acute illnesses, as well as in chronic diseases, including
diabetes and cancer [20,21]. Glutathione depletion has been clearly associated with cell damage
and apoptosis in vitro [22] and with increased mortality in clinical trials [20].
In this study, we aim to test the hypothesis that in patients with insulin resistance, after
major surgery, IIT, compare to CIT, would enhance glutathione synthesis and/or availability
and decrease systemic oxidative stress. To maximize insulin resistance, we have selected a pop-
ulation of well-nourished cancer patients, who had undergone abdominal radical surgery com-
bined with intra-operative radiation therapy. We have designed a 2-day randomized, cross-
over study to compare the effects of moderate hyperglycemia or euglycemia, induced by 24
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hours CIT or IIT given in randomized order [25], on glutathione synthesis in erythrocytes -as
determined by stable isotopic tracers [26],- and on plasma thiobarbituric acid reactive sub-
stance (TBARS) concentrations -as marker of lipid peroxydation [27],
Methods
Patients
We have enrolled 10 adult cancer patients (Table 1), with no other ongoing morbidities, from
the “Centro di Riferimento Oncologico, Istituto Nazionale Tumori” (IRCCS, Aviano, Italy),
admitted to ICU, after radical abdominal cancer surgery and intra-operative radiation therapy
[25]. The experimental protocol was approved by the ethical committee of the IRCCS. Written
informed consent was obtained from all patients before surgery. Protocol safety end-points
included hypoglycemia (glycaemia 79 mg/dl) and/or hypokalemia (kalemia 3.0 mg/dl).
Any patient reaching one of these end-points would have been excluded from the study.
Experimental design: The full experimental design is reported in our previous paper [25].
Briefly, all patients received a standard continuous intravenous infusion of glucose (20%
solution at 20 mL/kg/day), lipids (Intralipid 10% at 8 mL/kg/day) and mixed amino acids
(Freamine III 8.5% at 14.4 mL/kg/day), for a total energy intake of 28 kcal/kg/day. The experi-
mental procedure (Fig 1) started the day of surgery, at 2 PM, to precede over the next two 24
hour periods. Patients were assigned, according to a randomized crossover design, to either
IIT (insulin infused if glycaemia > 6.1 mmol/L, at dosages adjusted to maintain euglycaemia
between 4.4–6.9 mmol/L) [2,3] or CIT, as control treatment (insulin given if glycaemia > 9.4
mmol/L at dosages adjusted to maintain a moderate hyperglycaemia, between 8.3–11.1 mmol/
L). Five cases followed protocol 1 (i.e. IIT first, CIT second) and 5 cases protocol 2 (i.e. CIT
first, IIT second). Such a randomization was performed to account for possible time-related
changes in glutathione kinetics and oxidative stress, after surgery, and for the potential risks of
interference between the two stable isotope infusions, administered with such a tight schedule
[25]. Throughout the 2-day insulin infusion study, glycaemia was assessed every 2 hours. The
stable isotope infusion to determine erythrocyte glutathione kinetics and oxidative stress, was
performed during the last 7 h of insulin treatment (from 7 AM to 2 PM), in both IIT or CIT
[25]. In order to assess clinical stability between the two isotope infusions, hemodynamic indi-
ces (systolic and diastolic arterial pressure, heart rate and hematocrit) and plasma creatinine
concentrations, were determined before starting the infusion procedures.
Table 1. Patient characteristics.
Patient
#
Gender
(m/f)
Age
(yrs)
BMI
(kg/m2)
Diagnosis Protocola
1 m 53 21.6 colorectal cancer 2
2 m 50 29.1 colorectal cancer 2
3 m 52 23.4 colorectal cancer 1
4 m 70 26.5 colorectal cancer 1
5 f 54 27.7 colorectal cancer 2
6 m 73 25.9 retroperitoneal sarcoma 2
7 m 68 30.4 gastric cancer 1
8 m 69 21.1 gastric cancer 1
9 f 67 22.0 retroperitoneal sarcoma 1
10 f 36 23.3 endometrial cancer 2
a
, Protocol 1 (n = 5) = Intensive Insulin Therapy (IIT) first; Conventional Insulin Therapy (CIT) second. Protocol 2 (n = 5) = CIT first; IIT second
https://doi.org/10.1371/journal.pone.0190291.t001
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Isotope infusion procedure
Indwelling catheters, already placed for clinical purposes, in an internal jugular vein and in a
radial artery, were used for isotope infusion and blood samplings. At 7 A.M., after background
blood sampling, a primed-continuous infusion of 3.2±0.3 micromol/kg of L-[3,3-2H2]cysteine
(Cambridge Isotope Laboratories, Andover, MA) was started and continued for 7 hours. Arte-
rial blood samples (for a total of 10 mL) were obtained at 3, 4, 5, 6 and 7 hours, to measure
hematocrit and 2H2-enrichments of erythrocytes free-cysteine and glutathione [26]. Whole
blood samples were immediately centrifuged and plasma and erythrocytes were separated.
Erythrocytes were diluted with a known volume of cold distilled water. Plasma and erythrocyte
solutions were frozen at -80˚C for later analysis. Samples were processed as previously
described [26]. In plasma samples we measured the concentrations of TBARS and in both
plasma and erythrocyte the concentrations of glutathione and glutathione amino acid precur-
sors (glycine, glutamine, glutamate, methionine, homocysteine, and cysteine in plasma; gly-
cine, glutamine, glutamate, methionine, and cysteine in erythrocytes), as previously described
[26].
Analysis
Glutathione and cysteine isotopic enrichments were determined by gas chromatography-mass
spectrometry (GCMS) (HP 5890, Agilent Technologies, Santa Clara, CA, USA) as referenced
[26]. The N-methyl-N-tert-butyl-dimethysilyl-trifluoroacetamide derivatives were measured
by electron impact ionization and selective ion monitoring at a nominal mass-to-charge ratio
(m×z-1) of 363 and 365 for glutathione enrichment, and of 406 and 408 for cysteine enrich-
ment. Total glutathione and precursor amino acid concentrations in erythrocytes, obtained
Fig 1. Experimental procedure. The experimental procedure started at 2 PM, the day of surgery, and continued for the next 48-h, inclusive of the 24-h of
IIT and the 24-h of control CIT, administered according to randomized, cross-over protocols. Patients (n = 5) assigned to protocol 1 started with IIT, followed
by CIT, while patients (n = 5) assigned to protocol 2 started with CIT followed by IIT. Throughout the 2-day study, glycaemia was determined every 2 hours
(▲). The stable isotope infusion to determine erythrocyte glutathione kinetics and oxidative stress, was performed during the last 7 h of insulin treatment,
either IIT or CIT (i.e. from 7 AM to 2 PM). Shortly before starting the infusion (◆) a blood sample was taken to assess background isotope enrichments and
hematochemical and oxidative stress indices. Blood samples were taken at time 3,4,5,6,7 hour (▲) to assess the glutathione kinetics.
https://doi.org/10.1371/journal.pone.0190291.g001
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from background samples, were determined using GCMS and the internal standard technique
[23]. Plasma TBARS concentrations were measured using a commercially available kit (Oxitek,
Zeptometrix Co, Buffalo, NY), following the manufacturer’s recommendations. Catalytic sub-
unit expression of glutamate-cysteine ligase (GCL-C) in erythrocytes was measured by West-
ern blot analysis, as described [26]. GCL-C protein concentrations were assessed as a ratio
with glyceraldehyde-3-phosphate dehydrogenase protein.
Calculations
Isotopic enrichments were expressed as tracer-tracee-ratio (TTR). Erythrocyte glutathione and
amino acid concentrations were determined using standard calibration curves and normalized
by erythrocyte volume obtained from hematocrit micromol/L(HCT)]. Glutathione fractional
synthesis rate (FSR) (%/day) was calculated as follows:
FSR ¼ 100 24 ½Eð2H2glutathioneÞ=Eð
2H2cysteineÞ
Where, E(2H2glutathione)/t is the slope (TTR/h) of the regression line describing the rise in
erythrocyte 2H2-glutathione enrichment (TTR), as a function of time (hours), over the last 4 h
of isotope infusion, and 24 and 100 convert FSR to percent/per day. Glutathione absolute syn-
thesis rate was calculated by multiplying glutathione FSR by erythrocyte glutathione concen-
tration [26]. During each study day, glycaemia levels, assessed every 2 h throughout the study,
were plotted on a graph to geometrically calculate the area under the curve (AUC, mmol/L/h)
from 6 values of blood glucose concentrations, as referenced [26]. Mean blood glucose concen-
trations were calculated during the last 6 hours of each study period. To evaluate relative vari-
ability of glucose, the coefficient of variability (%) was calculated for each patient as mean of
standard deviations of glucose, divided by the mean, multiplied by 100 [27].
Statistics
Data are expressed as mean±SEM. The effects of insulin-mediated glucose control on all vari-
ables were analyzed with ANOVA, using treatment (IIT and CIT) as within-subject factor and
with protocol (1 and 2) as between-subject factor. Moreover, the effects on clinical data were
also analyzed with a repeated measure analysis of variance (ANOVA), with time (day 1 and
day 2) as within-subject factor. All comparisons were considered significant at p 0.05. Corre-
lation between variables were analyzed by Spearman’s coefficient. Statistical analysis was car-
ried out with SPSS software (version 21; SPSS Inc, Chicago, IL).
Results
All patients completed the protocol and none of them were excluded for safety reasons. Hemo-
dynamic and clinical chemistry indices showed no significant differences between IIT and CIT
(Table 2). Nonetheless, there was a significant treatment×protocol interaction for hemoglobin
levels. Hemoglobin significantly decreased by about 10% from study day 1 to study day 2 (12.0
±0.6 versus 10.7±0.5 g; p = 0.035). The hematocrit followed the same trend of hemoglobin
without achieving statistical significance. All patients required insulin infusion during both the
IIT and the CIT (control) and none of them had hypoglycemia episodes (i.e., blood
glucose < 3.9 mmol/L). IIT resulted in a tight glycemic control, while the conventional
approach (CIT) led to moderate hyperglycemia (Table 3). Insulin administration was 70%
lower during the control (CIT) than the IIT period (Table 3). There were no significant proto-
col effect or treatment×protocol interactions for insulin administration. Area under the curve
of glucose concentrations (AUCglycaemia) was significantly lower with IIT than with CIT
Accurate glycemic control reduces oxidative stress
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(Table 3). There were no significant treatment×protocol interactions for the AUCglycaemia. The
coefficient of variability of glucose was no significantly different during IIT as compare to CIT.
Precursor 2H2-cysteine enrichment was measured in erythrocytes and reached steady state in
all groups and insulin treatments (IIT or CIT) by the end of the third hour of isotope infusion,
whereas 2H2-glutathione enrichment in erythrocyte increased linearly with time (Fig 2). IIT
significantly increased glutathione fractional (+218±81%) and absolute (+233±88%) synthesis
rates in erythrocytes, being this result confirmed when normalized per hemoglobin content
(Table 4). Moreover, IIT significantly decreased plasma TBARS concentrations (-18±7%)
(Table 4). There were no significant treatment×protocol interactions for plasma TBARS and
erythrocyte glutathione synthesis. IIT did not change significantly glutathione or glutathione
precursor amino acid concentrations in erythrocytes (Table 5). Insulin-induced changes in
erythrocyte glutathione fractional synthesis rates inversely correlated with changes in plasma
TBARS concentrations at the end of each treatment (Fig 3).
Table 2. Clinical data during the experimental period.
CIT IIT p
Treatment effect Treatment × protocol
interaction
SAP (mmHg) 143±5 136±6 0.95 0.81
DAP (mmHg) 67±2 65±3 0.46 0.33
Heart rate (beats×min-1) 86±3 83±4 0.37 0.77
Hematocrit (%) 33±1 32±2 0.78 0.15
Hemoglobin (g×ml-1) 11.6±0.4 11.2±0.7 0.18 0.002
Platelets (109×L-1) 218±23 213±25 0.89 0.51
Leucocytes (109×L-1) 11.5±1.8 10.1±1.6 0.40 0.07
Sodium (mmol×L-1) 138±1 138±1 0.72 0.55
Potassium (mmol×L) 3.71±0.07 3.92±0.10 0.49 0.11
Creatinine (mg×dL-1) 0.76±0.08 0.78±0.09 0.79 0.17
Urea (mg×dL-1) 31.0±2.1 33.2±3.6 0.49 0.53
Data are expressed as means±SEMs. SAP, systolic arterial pressure; DAP, diastolic arterial pressure. Data were analyzed with repeated measures
ANOVA, with time as within subject variables (day 1 or day 2, after surgery) and sequence of treatments as between subject factors [Protocol 1 (n = 5),
intensive insulin therapy (IIT) first, conventional insulin therapy (CIT) second; protocol 2 (n = 5), CIT first, IIT second)].
https://doi.org/10.1371/journal.pone.0190291.t002
Table 3. Insulin infusion and glycemic control.
CIT IIT p
Treatment effects Treatment × protocol interaction
Insulin infusion (U×h-1) 1.2±0.5 4.0±1.0 0.03 0.15
Mean glucose concentration (mmol×L-1) 9.3±0.5 6.5±0.3 <0.001 0.49
AUC glucose (mmol×L-1×day-1) 223±12 154±7 0.002 0.40
Coefficient of variation of glucose (%) 9.7±1.4 10.5±1.1 0.43 0.56
IIT, Intensive insulin therapy; CIT, Conventional insulin therapy. Data are means±SEM of pooled values from protocols 1 and 2 obtained during the final 12
hours of CIT and IIT. AUC, area under the curve of blood glucose concentrations. Glucose variability throughout the experimental periods is expressed as
mean (±SEM) of individual standard deviations (SD). Data were analyzed with repeated measures ANOVA, with treatment as within subjects variables
(control and intensive insulin treatment) and sequence of treatments as between subjects factor [protocol 1 (n = 5), IIT first CIT second; protocol 2 (n = 5),
IIT first, CIT second].
https://doi.org/10.1371/journal.pone.0190291.t003
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Fig 2. Glutathione kinetic. Mean±SEM precursor 2H2-cysteine and product 2H2-glutathione tracer-to-tracee
ratios (TTRs) in erythrocytes during primed continuous infusion of 2H2-cysteine at the end of the control ()
and the intensive insulin treatment (●) periods.
https://doi.org/10.1371/journal.pone.0190291.g002
Table 4. Effects of intensive insulin treatment on systemic oxidative stress and glutathione synthesis.
CIT IIT p
Treatment effects Treatment × protocol interaction
Plasma TBARS
(nmol×mL-1)
2.9±0.4 2.2±0.2 0.04 0.54
Erythrocyte glutathione FSR
(%×day)
43±11 97±29 0.02 0.11
Erythrocyte glutathione ASR (mmol× L(HCT)-1×day-1) 1.18±0.29 2.70±0.51 0.01 0.12
Erythrocyte glutathione ASR (mmol×g(Hb)-1×day-1) 0.03±0.008 0.08±0.018 0.009 0.09
Erythrocyte GCL-C
(fraction of GAPDH)
0.73±0.08 0.83±0.22 0.61 0.42
IIT, Intensive insulin therapy; CIT, Conventional insulin therapy; HCT, hematocrit; Hb, hemoglobin, TBARS, thiobarbituric acid reactive substances; FSR,
fractional synthesis rate; ASR, absolute synthesis rate; GCL-C, glutamate cysteine ligase–catalytic subunit; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase. Data are means±SEM of pooled values from protocols 1 and 2 obtained at the end of CIT and IIT periods. Data were analyzed with
repeated measures ANOVA, with treatment as within subjects variables (control and intensive insulin treatment) and sequence of treatments as between
subjects factor [protocol 1 (n = 5), IIT first, CIT second; protocol 2 (n = 5), CIT first, IIT second].
https://doi.org/10.1371/journal.pone.0190291.t004
Accurate glycemic control reduces oxidative stress
PLOS ONE | https://doi.org/10.1371/journal.pone.0190291 January 4, 2018 7 / 12
Discussion
Glutathione synthesis rate is a key determinant of intracellular antioxidant capacity. We have
shown in non-diabetic cancer patients that IIT, by preventing post-surgical stress hyperglyce-
mia, was associated with increased glutathione synthesis and decreased systemic oxidative
stress. Glutathione synthesis rates were measured in erythrocytes from the incorporation of
labeled cysteine (precursor) into glutathione (product) [26]. Systemic oxidative stress was
determined as plasma TBARS concentrations [27]. Insulin-mediated changes in glutathione
synthesis rate correlated inversely with changes in plasma TBARS concentrations, showing the
role of insulin or of changes in glycaemia levels in the regulation of oxidative stress.
All enrolled patients developed hyperglycemia and required insulin treatment, after surgery
and intra-operative radiation therapy. We used a cross-over experimental design to compare
the effects of conventional (CIT) or intensive (IIT) 24-h insulin therapy, given in randomized
order, over 48-h after surgery [25]. IIT resulted in a tight glycemic control, while CIT led to
Table 5. Effects of intensive insulin treatment on erythrocyte glutathione and precursor amino acid concentrations.
CIT IIT P
Treatment effects Treatment × protocol
interaction
Glutathione [micromol×L(HCT)-1] 2783±183 3045±378 0.37 0.43
Glutathione [micromol×g(Hb)-1] 244.4±20.8 284.3±41.9 0.16 0.09
Cysteine [micromol×L(HCT)-1] 51±4 48±4 0.47 0.42
Glutamate [micromol×L(HCT)-1] 535±140 446±36 0.55 0.39
Glycine [micromol×L(HCT)-1] 448±23 469±20 0.11 0.81
IIT, Intensive insulin therapy; CIT, Conventional insulin therapy; HCT, hematocrit; Hb, hemoglobin. Data are means±SEMs of pooled values from protocols
1 and 2, obtained at the end of the control and the intensive insulin treatment periods. Data were analyzed with repeated measures ANOVA, with treatment
as within subjects variables (control and the intensive insulin treatment) and sequence of treatments as between subjects factor [protocol 1 (n = 5), IIT first,
CIT second; protocol 2 (n = 5), CIT first, IIT second]. There were no significant protocol effects for any of the parameters.
https://doi.org/10.1371/journal.pone.0190291.t005
Fig 3. Relationship between insulin mediated changes in erythrocyte glutathione fractional synthesis
rate (FSR) and plasma thiobarbituric acid reactive substances (TBARS). Spearman’s correlation
coefficient, -0.69; n = 10; p = 0.03.
https://doi.org/10.1371/journal.pone.0190291.g003
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moderate hyperglycemia. The sequence of post-surgical insulin treatments was randomized to
prevent potential time-related metabolic effects. Since there were no differences between the
two protocols, euglycemia results from IIT, either on day 1 or 2 after surgery, were pooled and
compared with pooled hyperglycemia data from CIT), either on day 1 or 2 after surgery.
Thereafter the statistical interactions between time after surgery and insulin treatment were
assessed [25]. Despite the fact that we found no insulin/euglycemia effects on hemoglobin lev-
els, there was a significant treatment × protocol interaction. In fact, there was a significant 10%
decrease in hemoglobin levels from study day 1 to study day 2 due to fluid therapy. The hemat-
ocrit followed the same trend of hemoglobin without achieving statistical significance.
In our study, both IIT and CIT were characterized by absence of hypoglycemic episodes
and by low-glycemic variability. It is well known that both glycemic excursions and hypoglyce-
mia are major determinants of ROS production, redox system unbalance and glutathione
depletion [28–31]. Moreover, mild hypoglycemia, as defined by blood glucose < 3.9 mmol/L,
was associated with increased morbidity and mortality in ICU patients [32,33]. In our study,
the ratios of glycemic variations, compared to the mean patient’s values, calculated as coeffi-
cient of variability, were about 10%, both in IIT and CIT. In a large cohort of 7049 mixed ICU
patients the mean coefficient of variability of plasma glucose was about double than that
observed in our study [33]. Glucose variability is an independent predictor of morbidity and
mortality in ICU [8,34]. Continuous blood glucose–monitoring devices and computer-assisted
closed loop systems for insulin delivery have been shown to prevent hypoglycemia and reduce
glucose variability in ICU settings [17,18].
Previous evidence indicates that tissue glutathione synthesis capacity is decreased by surgi-
cal trauma [21]. The enzyme glutamate-cysteine ligase, which catalyzes the first and rate limit-
ing reaction involved in glutathione biosynthesis, starting from cysteine and glutamate, is
induced by reactive oxygen species, but down-regulated by stress hormones, as glucocorticoids
and catechol amines [20]. In the present study, insulin-mediated tight glucose control, after
surgery, doubled glutathione synthesis rates in erythrocytes, as compared to the condition of
relative insulin deficiency with moderate hyperglycemia. In perfect agreement with our results,
insulin infusion to control hyperglycemia in experimental sepsis, increased glutathione con-
tent in the liver by 78% [29]. Evidence indicates that glutathione metabolism, as assessed in the
erythrocytes, may reflect the conditions of both whole body and liver glutathione system [20].
Expression levels of catalytic subunits of the glutamate-cysteine ligase enzyme did not change
following CIT or IIT, suggesting a post-translational regulation of enzyme activity by insulin
and/or changes in glucose levels. The differential effects of insulin and glucose on glutamate-
cysteine ligase activity have been assessed in experimental models of insulin deficiency. Insulin
can directly activate this enzyme and stimulate glutathione synthesis, independently from glu-
cose concentration [24]. In addition to de novo synthesis, other mechanisms can affect intra-
cellular glutathione pool and turnover. Detoxifying reactions involving generation of
glutathione-S-conjugates by glutathione-S-transferases can decrease intracellular glutathione
pools [20]. These pathways are activated by trauma and infections, as well as by insulin deple-
tion and hyperglycemia, leading to accelerated glutathione disposal [20,30]. High levels of
blood glucose are typically accompanied by increased production of free radicals, indepen-
dently from insulin availability in patients with type 2 diabetes or stress hyperglycemia [20,
35]. In our study, therefore, either insulin-mediated improvement of anti-oxidant defenses or
lower free radical production, secondary to euglycemia, could have contributed to decreasing
plasma TBARS, following surgical stress. The observed inverse correlation between changes in
glutathione synthesis rate and TBARS, suggests a cause-effect relationship between increased
glutathione availability and improved redox balance.
Accurate glycemic control reduces oxidative stress
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We have used plasma TBARS concentrations as index of lipid peroxidation and systemic
redox unbalance. Insulin-mediated tight glycemic control (IIT) significantly decreased TBARS
concentrations by 15%, as compared to conventional insulin treatment (CIT) and moderate
hyperglycemia. Both IIT and CIT may have contributed to decreasing systemic oxidative
stress. In population-based studies, glucose levels directly correlated with TBARS in healthy
individuals and in type 2 diabetics [34]. In physiological conditions, a diet with a high glycemic
index was associated with greater oxidative stress, as measured by lipid peroxidation markers
[36]. Tight metabolic control reduced TBARS in type 1 diabetic individuals [37]. Thus, our
results are in perfect agreement with previous evidence suggesting a direct contribution of
euglycemia in lowering lipid peroxidation markers.
Conclusion
Stress hyperglycemia, independent from previous history of diabetes mellitus, is a frequent
finding after major surgery, with a strong impact on patient’s outcome. We investigated the
beneficial effects of IIT on oxidative stress in post-surgical patients. Our results underscore
the potential of IIT in post-operative ICU patients to stimulate glutathione synthesis and
decrease systemic oxidative stress, in the absence of hypoglycemic episodes and with low-
glycemic variability. These findings have significant clinical implications since surgical
trauma decreases the synthetic capacity and availability of glutathione [21] increasing mor-
bidity and mortality [22].
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